ACCESS Newswire

Glenmorgan Investments Reopens Digital Asset Innovation Fund

22.1.2025 08:00:00 CET | ACCESS Newswire | Press release

Share

Glenmorgan Investments Announces the Reopening of Its Digital Asset Innovation Fund to New Investors Following Record-Breaking Performance and Enhanced Regulatory Clarity

LONDON, UK / ACCESS Newswire / January 22, 2025 / Glenmorgan Investments Limited, a leading provider of award-winning fund management services since 1999, has announced the reopening of its highly sought-after Digital Asset Innovation Fund to new investors. The fund, which was initially capped in March 2024 due to unprecedented demand, will now have its cap increased to $1 billion from the original $500 million limit, following significant performance milestones and enhanced regulatory clarity in the digital asset landscape.

The Digital Asset Innovation Fund, launched in 2018, has delivered exceptional returns, achieving record-breaking performance in 2024 and into 2025. The fund focuses on high-growth opportunities within the digital asset space, including cryptocurrencies and blockchain technology. Amid growing interest from both retail and institutional investors, the fund was capped in March 2024 to manage liquidity and ensure its continued success as digital assets experienced large inflows amid heightened media attention and ETF approvals.

"We are excited to reopen the Digital Asset Innovation Fund to new investors at this pivotal moment," said Mr. Sam Hargate, Chief Financial Officer of Glenmorgan Investments. "Since its inception, the fund has provided outstanding returns, and we believe the current market conditions-coupled with the completion of the US elections and forthcoming regulatory clarity-are ideal for expanding our capacity. Our decision to increase the cap reflects our commitment to providing both existing and new clients with access to a dynamic and high-performing investment vehicle."

The fund's reopening follows significant shifts in the digital asset market, which has become increasingly popular with institutional investors, supported by the US election results and an evolving regulatory framework for digital assets. With growing institutional involvement and expected oversight by regulatory bodies, Glenmorgan Investments sees an opportunity to continue leveraging its expertise in managing private funds focused on alternative assets.

"This is a unique time for investors in the digital asset space, and Glenmorgan is well-positioned to help our clients capitalize on the tremendous potential of this sector," said Mr. Sam Hargate. "Our focus has always been on managing risk while delivering exceptional returns, and we remain committed to maintaining the highest standards of transparency and compliance."

The Digital Asset Innovation Fund has been instrumental in offering investors exposure to one of the fastest-growing and most disruptive asset classes of the modern era. With its record-breaking returns and established track record of excellence, Glenmorgan Investments continues to lead the way in providing innovative solutions for both retail and institutional investors alike.

About Glenmorgan Investments Limited:

Glenmorgan Investments Limited, founded in 1999, is a globally recognized provider of award-winning fund management services. With a strong presence in London, the Isle of Man and Australia, Glenmorgan specializes in managing private funds for retail and institutional clients in the UK, Europe and the rest of the world. Focused on high-growth alternative asset classes, the company offers a comprehensive range of investment opportunities, with a proven track record of delivering exceptional returns across diverse alternative markets.

Media Contact:

Mrs. Susan Harper
Media and Public Relations Manager

Email: media@glenmorganinvestments.com
Tel: +44(0)20 3355 9612
Web: www.glenmorganinvestments.com
Address: City Reach, 5-6 Greenwich View Place, London E14 9NN, United Kingdom

SOURCE: Glenmorgan Investments Limited



View the original press release on ACCESS Newswire

Glenmorgan Investments Limited

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release

Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica

Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release

OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release

CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a

Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in

CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release

TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye